Adma Biologics (ADMA) EBT Margin Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) EBT Margin Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -4,971.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,971.00 |
| Sep 30, 2025 | 7,164.00 |
| Jun 30, 2025 | 5,120.00 |
| Mar 31, 2025 | 9,157.00 |
| Dec 31, 2024 | 7,525.00 |
| Sep 30, 2024 | 11,641.00 |
| Jun 30, 2024 | 13,901.00 |
| Mar 31, 2024 | 13,674.00 |
| Dec 31, 2023 | 17,113.00 |
| Sep 30, 2023 | 16,670.00 |
| Jun 30, 2023 | 24,843.00 |
| Mar 31, 2023 | 17,669.00 |
| Dec 31, 2022 | 5,979.00 |
| Sep 30, 2022 | 12,185.00 |
| Jun 30, 2022 | 19,227.00 |
| Mar 31, 2022 | 35,194.00 |
| Dec 31, 2021 | 39,618.00 |
| Sep 30, 2021 | 27,164.00 |
| Jun 30, 2021 | 21,351.00 |
| Mar 31, 2021 | 33,076.00 |